Business Wire

SEOUL-SEMICONDUCTOR

24.5.2017 09:09:07 CEST | Business Wire | Press release

Share
Seoul Semiconductor Continuously Pursues patent infringement actions against Everlight products

Seoul Semiconductor Co., Ltd. (KOSDAQ 046890) — On April 28, 2017, Seoul Semiconductor Europe GmbH (“Seoul”) filed a patent infringement claim in Germany at the District Court of Düsseldorf against Mouser Electronic Inc. (“Mouser), a global electronic components distributor, which it accused of selling Everlight LED products.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170524005266/en/

In its complaint, Seoul asserted that Everlight’s Mid-Power LED products are infringing Seoul’s patent rights. Seoul has sought a permanent injunction, damages, and recall and destruction of the allegedly infringing products.

The asserted patent serves to improve the light extraction performance of LED devices by enhancing internal-reflection efficiency, which has been widely used in mid-power and high-power LEDs.

This patent litigation is the second patent infringement litigation by Seoul or its affiliate affecting Everlight’s LED products. In March 2017, Seoul Semiconductor Co., Ltd. filed a patent infringement claim in Germany, accusing high-power LED products manufactured by Everlight as well as other LED manufacturers. These patent litigations underscore Seoul’s commitment to protecting its intellectual property rights against infringement, including products consisting of mid-power LEDs and high-power LEDs.

In addition to Seoul’s patent infringement actions, Everlight has been implicated in other patent infringement lawsuits as described below. Nam Ki-bum, Vice President of the Research Center at Seoul, said, “Several LED companies have grown rapidly in a short period of time despite a lack of valuable patent portfolios, which is like building a castle on quicksand. There is no underlying foundation for the company’s products. Seoul, however, has been investing 10% of its revenue in research and development for many years to develop innovative technology and strengthen our patent portfolio. To support a fair market that respects intellectual property rights, Seoul will continuously monitor and take action against alleged infringers in any countries where infringement occurs.”

* Reference [source: various media news articles]

Plaintiff   Defendant   Business Relation   Patented Technology   Courts   State   Link
Nichia   WOFI Leuchten   Everlight subsidiary   phosphor   Düsseldorf District Court, Germany   Nichia won the suit in the court of first instance and the court ruled for an injunction  

http://www.ledinside.com/news/2016/12
/nichia_clinches_two_legal_victories_ag
ainst_everlight_in_german_district_court
s

http://www.nichia.co.jp/en/about_nichia/2
016/2016_122102.html

Nichia   REGO-Lighting   Used a white LED tube light product by Everlight subsidiary Zenar   phosphor   Düsseldorf District Court, Germany   On Dec. 5, 2016, the appeals court confirmed patent infringement and ruled in favor of Nichia.  

http://www.nichia.co.jp/en/about_nichia/2
016/2016_122101.html

http://www.ledinside.com/news/2016/12/
nichia_clinches_two_legal_victories_aga
inst_everlight_in_german_district_courts

Nichia   Everlight   Everlight   phosphor   Düsseldorf District Court, Germany   On Oct. 24, 2016, the court granted a preliminary injunction.  

http://www.nichia.co.jp/en/about_nichia/2
016/2016_111701.html

http://www.ledinside.com/news/2016/11/
german_court_grants_nichia_preliminary
_injunctions_for_white_led_products_that
_infringed_patents

Nichia   Tachibana Eletech and E&E Japan   Distributor of blue LEDs manufactured by Everlight in Japan   LED chip   Tokyo District Court, Japan   On Oct. 14, 2016, the court issued an oder ruled for an infringement in favor of Nichia.  

http://www.nichia.co.jp/en/about_nichia/2016
/2016_102001.html

http://www.ledinside.com/press/2016/10/nich
ia_wins_patent_infringement_lawsuit_agains
t_tachibana_and_ee_japan_in_tokyo

Nichia   Mouser   Distributor of Everlight products   phosphor   Düsseldorf District Court, Germany   On Oct. 7, 2016, the court granted a preliminary injunction.  

http://www.nichia.co.jp/en/about_nichia/2
016/2016_101301.html

http://www.ledinside.com/news/2016/10/g
erman_court_grants_preliminary_injunctio
n_against_mouser_based_on_nichia_yag
_patent

Nichia   Everlight   Everlight   LED Package   The U.S. District Court for the Eastern District of Texas   The Federal Circuit affirmed an infringement of Nichia’s patents.  

http://www.nichia.co.jp/en/about_nichia/20
17/2017_050901.html

http://www.ledinside.com/news/2017/5/nic
hia_wins_important_victory_in_federal_ci
rcuit_appeal

Nichia   EBV Elektronik GmbH & Co. KG and EBV Management GmbH (both “EBV“)   Distributor of Everlight products   phosphor   Düsseldorf District Court, Germany   Still in progress  

http://www.nichia.co.jp/en/about_nichia
/2017/2017_030802.html

http://www.ledinside.com/press/2017/3/nichia

_files_patent_infringement_lawsuit_against_

ebv_in_germany_regarding_white_led_

product_of_everlight

Nichia   Everlight Electronics (China) and Beijing Ducheng Yiguang Electronic Devices Selling Center   Everlight subsidiary   phosphor   Beijing Intellectual Property Court, China   Still in progress  

http://www.nichia.co.jp/en/about_nichia
/2016/2016_032401.html

http://www.ledinside.com/news/2016/3/
nichia_files_new_led_patent_infringem
ent_lawsuits_respectively_in_china_an
d_us

Seoul Semiconductor   Mouser   Distributor of Everlight products   High Power LED   Düsseldorf District Court, Germany   Still in progress  

http://www.ledinside.com/news/2017/4/se
oul_semiconductor_files_patent_infringe
ment_lawsuit_in_germany

Seoul Semiconductor   Mouser   Distributor of Everlight products   Mid Power LED   Düsseldorf District Court, Germany   On April 28, 2017, Seoul filed the lawsuit.    
           

About Seoul Semiconductor:

Seoul Semiconductor develops and commercializes light emitting diodes (LEDs) for automotive, general illumination, specialty lighting, and backlighting markets. As the fifth-largest LED manufacturer globally, Seoul Semiconductor holds more than 12,000 patents, offers a wide range of technologies, and mass produces innovative LED products such as Wicop – a simpler structured Package-Free LED which provides market leading color uniformity, cost savings at the fixture level with high lumen density and allows design flexibility; Acrich, the world's leading direct AC LED; Acrich MJT multi-junction technology; a proprietary family of high-voltage LEDs; NanoDriver Series – World’s Smallest 24W DC LED Drivers and nPola, a new LED product based on GaN-substrate technology that achieves over ten times the output of conventional LEDs.

For more information about Seoul Semiconductor, please visit http://www.seoulsemicon.com

# Trademarks: Wicop and Acrich are trademarks of Seoul Semiconductor Co., Ltd.

Contact:

Asia
Seoul Semiconductor Co., Ltd
Jake Jung, +82 070.4391.8270
Email: pr@seoulsemicon.com
or
Europe
Seoul Semiconductor Europe GmbH
Ariane Heim, +49 (0)89 450 3690-0
Email: press.eu@seoulsemicon.com
or
North America
Seoul Semiconductor Inc.
David Cox, +1 (919) 410-9856
Email: David.cox@seoulsemicon.com

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities27.4.2026 16:00:00 CEST | Press release

As pharma manufacturers prioritize US supply chain resilience, highlights include high-speed isolator filling lines for prefilled syringes, cartridges and vials, and drug-device combination assembly and packaging. PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers and their development partners increasingly prioritize US supply chain resilience, PCI’s latest investments come as part of a broader commitment exceeding $1 billion across the CDMO’s US and European operations, reinforcing its ability to provide seamless support for drug product development and manufacturing, clinical trial supply and drug-device combination assembly from clinical stages through commercial launch – all underpi

Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors27.4.2026 15:53:00 CEST | Press release

Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, is pleased to announce that world-renowned inventor and battery expert Dr. Yuan Gao has joined the company’s Board of Directors. Dr. Gao has been an invaluable member of Pure Lithium’s Scientific Advisory Board since October of 2023. "We are thrilled to have Dr. Gao join our board as we focus on rapidly scaling our technology in the most capital efficient manner possible,” said Pure Lithium Founder, Chairman and CEO Emilie Bodoin. “Dr. Gao is a brilliant scientist who also has deep commercial expertise, a rare combination. He is also unique in the industry because his experience spans the entire battery materials value chain, including all of Pure Lithium’s verticals. His insights over the years have been critical in advancing our technology, and his experience as a director of public companies will strengthen our board.” Dr. Gao commented: “I am thrilled to join the board of Pure Lithium Corpor

Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 15:00:00 CEST | Press release

Phase 1 dose-escalation trial represents the first clinical trial of a product developed using the AraLinQ™ ADC technology and marks Taiho’s expansion into the clinical development of ADCs for oncology Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug co

Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 202627.4.2026 15:00:00 CEST | Press release

Premier global event to highlight how organizations are bringing data to life to power everything from AI to BI Boomi, the data activation company, today announced Boomi World 2026, its premier annual user conference, taking place May 11 - 14, 2026 in Chicago, IL. The event will bring together customers, partners, and industry leaders from around the world to explore how data activation is transforming the enterprise and accelerating the path to AI-driven outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427600340/en/ Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 2026 Boomi World 2026 will spotlight data activation — bringing data to life to power AI, analytics, and intelligent automation. Attendees will gain firsthand insights into how the Boomi Enterprise Platform enables businesses to unify data, streamline operations, and innovate faster in an increasingly agentic world.

Axinn Appoints Rachael Philbin as Chief Innovation Officer27.4.2026 15:00:00 CEST | Press release

Appointment Reflects Firm's Vision for the Future of Legal Practice Axinn, Veltrop & Harkrider LLP today announced the appointment of Rachael Philbin as Chief Innovation Officer, reinforcing the firm’s continued investment in advanced solutions and technology for legal services delivery. Philbin joins from Proskauer Rose LLP, where she served as Innovation & Transformation Officer. Based in Axinn's New York office, she will lead the firm’s AI and legal technology initiatives as well as knowledge management efforts, accelerating adoption and integration across its antitrust, intellectual property, and litigation practices. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427277725/en/ Rachael Philbin joins Axinn, Veltrop & Harkrider LLP as Chief Innovation Officer. “As Axinn continues to grow, we are making deliberate investments in the capabilities that enable our lawyers to deliver service and results at the highest level

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye